Immune Responses to Retroviruses

Annual Review of Immunology

Volumn 36, Issue , 2018, Pages 193-220

  Sáez Cirión, Asier ^a   Manel, Nicolas ^b  

^a INSTITUT PASTEUR   (France)

^b PSL RESEARCH UNIVERSITY   (France)

Author keywords

HIV; Innate immunity; Pathogen recognition; Pathogenesis; Protective immunity; Retroviruses

Indexed keywords

INTERFERON; VIRUS DNA; VIRUS RNA;

ADAPTIVE IMMUNITY; ARTICLE; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; DENDRITIC CELL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; INNATE IMMUNITY; LYMPHOID ORGAN; MURINE LEUKEMIA VIRUS; NONHUMAN; PRIORITY JOURNAL; RETROVIRIDAE; RETROVIRUS INFECTION; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; T LYMPHOCYTE; VIRUS PARTICLE; VIRUS REPLICATION; VIRUS TRANSMISSION; ANIMAL; CYTOLOGY; HOST PATHOGEN INTERACTION; IMMUNE EVASION; IMMUNE SYSTEM; IMMUNOLOGY; METABOLISM; VIROLOGY;

ADAPTIVE IMMUNITY; ANIMALS; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNE EVASION; IMMUNE SYSTEM; IMMUNITY, INNATE; RETROVIRIDAE; RETROVIRIDAE INFECTIONS;

EID: 85045837851     PISSN: 07320582     EISSN: 15453278     Source Type: Book Series    
DOI: 10.1146/annurev-immunol-051116-052155     Document Type: Article

References (221)

1. Pertel T, Hausmann S, Morger D, Zuger S, Guerra J, et al. 2011. TRIM5 is an innate immune sensor for the retrovirus capsid lattice. Nature 472:361-65
2. Portilho DM, Fernandez J, Ringeard M, Machado AK, Boulay A, et al. 2016. Endogenous TRIM5α function is regulated by SUMOylation and nuclear sequestration for efficient innate sensing in dendritic cells. Cell Rep. 14:355-69
3. Galao RP, Pickering S, Curnock R, Neil SJ. 2014. Retroviral retention activates a Syk-dependent HemITAM in human tetherin. Cell Host Microbe 16:291-303
4. Monajemi M, Woodworth CF, Benkaroun J, Grant M, Larijani M. 2012. Emerging complexities of APOBEC3G action on immunity and viral fitness during HIV infection and treatment. Retrovirology 9:35
5. Lahaye X, Manel N. 2015. Viral and cellular mechanisms of the innate immune sensing of HIV. Curr. Opin. Virol. 11:55-62
6. Silvin A, Manel N. 2015. Innate immune sensing of HIV infection. Curr. Opin. Immunol. 32:54-60
7. Sporri R, Reis e Sousa C. 2005. Inflammatory mediators are insufficient for full dendritic cell activation and promote expansion of CD4+ T cell populations lacking helper function. Nat. Immunol. 6:163-70
8. Heil F, Hemmi H, Hochrein H, Ampenberger F, Kirschning C, et al. 2004. Species-specific recognition of single-stranded RNA via Toll-like receptor 7 and 8. Science 303:1526-29
9. Kwa S, Kannanganat S, Nigam P, Siddiqui M, Shetty RD, et al. 2011. Plasmacytoid dendritic cells are recruited to the colorectum and contribute to immune activation during pathogenic SIV infection in rhesus macaques. Blood 118:2763-73
10. Odendall C, Dixit E, Stavru F, Bierne H, Franz KM, et al. 2014. Diverse intracellular pathogens activate type III interferon expression from peroxisomes. Nat. Immunol. 15:717-26
11. Swiecki M, Gilfillan S, Vermi W, Wang Y, Colonna M. 2010. Plasmacytoid dendritic cell ablation impacts early interferon responses and antiviral NK and CD8+ T cell accrual. Immunity 33:955-66
12. Brewitz A, Eickhoff S, Dahling S,Quast T, Bedoui S, et al. 2017. CD8+ Tcells orchestrate pDC-XCR1+ dendritic cell spatial and functional cooperativity to optimize priming. Immunity 46:205-19
13. Hardy AW, Graham DR, Shearer GM, Herbeuval JP. 2007. HIV turns plasmacytoid dendritic cells (pDC) into TRAIL-expressing killer pDC and down-regulates HIV coreceptors by Toll-like receptor 7-induced IFN-α. PNAS 104:17453-58
14. Niess JH, Brand S, Gu X, Landsman L, Jung S, et al. 2005. CX3CR1-mediated dendritic cell access to the intestinal lumen and bacterial clearance. Science 307:254-58
15. Silvin A, Yu CI, Lahaye X, Imperatore F, Brault J-B, et al. 2017. Constitutive resistance to viral infection in human CD141+ dendritic cells. Sci. Immunol. 2:eaai8071
16. Browne EP. 2013. Toll-like receptor 7 inhibits early acute retroviral infection through rapid lymphocyte responses. J. Virol. 87:7357-66
17. Kane M, Case LK, Wang C, Yurkovetskiy L, Dikiy S, Golovkina TV. 2011. Innate immune sensing of retroviral infection via Toll-like receptor 7 occurs upon viral entry. Immunity 35:135-45
18. Geijtenbeek TB, Kwon DS, Torensma R, van Vliet SJ, van Duijnhoven GC, et al. 2000. DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells. Cell 100:587-97
19. Gringhuis SI, den Dunnen J, Litjens M, van der Vlist M, Geijtenbeek TB. 2009. Carbohydrate-specific signaling through the DC-SIGN signalosome tailors immunity to Mycobacterium tuberculosis, HIV-1 and Helicobacter pylori. Nat. Immunol. 10:1081-88
20. MorisA,Nobile C, Buseyne F, Porrot F,Abastado JP, Schwartz O. 2004.DC-SIGNpromotes exogenous MHC-I-restricted HIV-1 antigen presentation. Blood 103:2648-54
21. Hodges A, Sharrocks K, EdelmannM, Baban D, Moris A, et al. 2007. Activation of the lectin DC-SIGN induces an immature dendritic cell phenotype triggering Rho-GTPase activity required for HIV-1 replication. Nat. Immunol. 8:569-77
22. Granelli-Piperno A, Golebiowska A, Trumpfheller C, Siegal FP, Steinman RM. 2004. HIV-1-infected monocyte-derived dendritic cells do not undergo maturation but can elicit IL-10 production and T cell regulation. PNAS 101:7669-74
23. Gringhuis SI, Hertoghs N, KapteinTM,Zijlstra-WillemsEM,Sarrami-Fooroshani R, et al. 2017. HIV-1 blocks the signaling adaptor MAVS to evade antiviral host defense after sensing of abortive HIV-1 RNA by the host helicase DDX3. Nat. Immunol. 18:225-35
24. Decalf J, Desdouits M, Rodrigues V, Gobert FX, Gentili M, et al. 2017. Sensing ofHIV-1 entry triggers a type I interferon response in human primary macrophages. J. Virol. 91:e00147-17
25. Manel N, Hogstad B, Wang Y, Levy DE, Unutmaz D, Littman DR. 2010. A cryptic sensor for HIV-1 activates antiviral innate immunity in dendritic cells. Nature 467:214-17
26. Rasaiyaah J, Tan CP, Fletcher AJ, Price AJ, Blondeau C, et al. 2013. HIV-1 evades innate immune recognition through specific cofactor recruitment. Nature 503:402-5
27. Yan N, Regalado-Magdos AD, Stiggelbout B, Lee-Kirsch MA, Lieberman J. 2010. The cytosolic exonuclease TREX1 inhibits the innate immune response to human immunodeficiency virus type 1. Nat. Immunol. 11:1005-13
28. Doitsh G, Galloway NL, Geng X, Yang Z, Monroe KM, et al. 2014. Cell death by pyroptosis drives CD4 T-cell depletion in HIV-1 infection. Nature 505:509-14
29. Doitsh G, Cavrois M, Lassen KG, Zepeda O, Yang Z, et al. 2010. Abortive HIV infection mediates CD4 T cell depletion and inflammation in human lymphoid tissue. Cell 143:789-801
30. Doitsh G, Greene WC. 2016. Dissecting how CD4 T cells are lost during HIV infection. Cell Host Microbe 19:280-91
31. Munoz-Arias I, Doitsh G, Yang Z, Sowinski S, Ruelas D, Greene WC. 2015. Blood-derived CD4 T cells naturally resist pyroptosis during abortive HIV-1 infection. Cell Host Microbe 18:463-70
32. Monroe KM, Yang Z, Johnson JR, Geng X, Doitsh G, et al. 2014. IFI16 DNA sensor is required for death of lymphoid CD4 T cells abortively infected with HIV. Science 343:428-32
33. Hornung V, Ablasser A, Charrel-Dennis M, Bauernfeind F, Horvath G, et al. 2009. AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASC. Nature 458:514-18
34. Thompson MR, Sharma S, AtianandM, Jensen SB, Carpenter S, et al. 2014. Interferon gamma-inducible protein (IFI) 16 transcriptionally regulates type I interferons and other interferon-stimulated genes and controls the interferon response to both DNA and RNA viruses. J. Biol. Chem. 289:23568-81
35. Vance RE. 2016. Cytosolic DNA sensing: the field narrows. Immunity 45:227-28
36. Goldfeld AE, Birch-Limberger K, Schooley RT, Walker BD. 1991. HIV-1 infection does not induce tumor necrosis factor-alpha or interferon-beta gene transcription. J. Acquir. Immune Defic. Syndr. 4:41-47
37. Vermeire J, Roesch F, Sauter D, Rua R, Hotter D, et al. 2016. HIV triggers a cGAS-dependent, Vpuand Vpr-regulated type I interferon response in CD4+ T cells. Cell Rep. 17:413-24
38. Hosmalin A, McIlroy D, Cheynier R, Clauvel JP, Oksenhendler E, et al. 1995. Splenic interdigitating dendritic cells in humans: characterization and HIV infection frequency in vivo. Adv. Exp. Med. Biol. 378:439-41
39. Hertoghs N, van der Aar AM, Setiawan LC, Kootstra NA, Gringhuis SI, Geijtenbeek TB. 2015. SAMHD1 degradation enhances active suppression of dendritic cell maturation by HIV-1. J. Immunol. 194:4431-37
40. Manel N, Littman DR. 2011. Hiding in plain sight: how HIV evades innate immune responses. Cell 147:271-74
41. Lahaye X, Satoh T, Gentili M, Cerboni S, Conrad C, et al. 2013. The capsids of HIV-1 and HIV-2 determine immune detection of the viral cDNA by the innate sensor cGAS in dendritic cells. Immunity 39:1132-42
42. SunseriN,O'Brien M, Bhardwaj N, Landau NR. 2011. Human immunodeficiency virus type 1modified to package simian immunodeficiency virus Vpx efficiently infectsmacrophages and dendritic cells. J. Virol. 85:6263-74
43. Gao D, Wu J, Wu YT, Du F, Aroh C, et al. 2013. Cyclic GMP-AMP synthase is an innate immune sensor of HIV and other retroviruses. Science 341:903-6
44. Bloch N, O'Brien M, Norton TD, Polsky SB, Bhardwaj N, Landau NR. 2014. HIV type 1 infection of plasmacytoid and myeloid dendritic cells is restricted by high levels of SAMHD1 and cannot be counteracted by Vpx. AIDS Res. Hum. Retroviruses 30:195-203
45. Yoh SM, Schneider M, Seifried J, Soonthornvacharin S, Akleh RE, et al. 2015. PQBP1 is a proximal sensor of the cGAS-dependent innate response to HIV-1. Cell 161:1293-305
46. Bobadilla S, Sunseri N, Landau NR. 2013. Efficient transduction of myeloid cells by an HIV-1-derived lentiviral vector that packages the Vpx accessory protein. Gene. Ther. 20:514-20
47. Puigdomenech I, Casartelli N, Porrot F, Schwartz O. 2013. SAMHD1 restricts HIV-1 cell-to-cell transmission and limits immune detection in monocyte-derived dendritic cells. J. Virol. 87:2846-56
48. Maelfait J, Bridgeman A, Benlahrech A, Cursi C, Rehwinkel J. 2016. Restriction by SAMHD1 limits cGAS/STING-dependent innate and adaptive immune responses to HIV-1. Cell Rep. 16:1492-501
49. Rowland-Jones SL, Whittle HC. 2007. Out of Africa: what can we learn from HIV-2 about protective immunity to HIV-1? Nat. Immunol. 8:329-31
50. de Silva TI, Cotten M, Rowland-Jones SL. 2008. HIV-2: the forgotten AIDS virus. Trends Microbiol. 16:588-95
51. Esbjornsson J, Mansson F, Kvist A, Isberg PE, Nowroozalizadeh S, et al. 2012. Inhibition of HIV-1 disease progression by contemporaneous HIV-2 infection. N. Engl. J. Med. 367:224-32
52. Schindler M, Munch J, Kutsch O, Li H, Santiago ML, et al. 2006. Nef-mediated suppression of T cell activation was lost in a lentiviral lineage that gave rise to HIV-1. Cell 125:1055-67
53. Arien KK, Abraha A, Quinones-Mateu ME, Kestens L, VanhamG, Arts EJ. 2005. The replicative fitness of primary human immunodeficiency virus type 1 (HIV-1) group M, HIV-1 group O, andHIV-2 isolates. J. Virol. 79:8979-90
54. Campbell EM, Hope TJ. 2015. HIV-1 capsid: the multifaceted key player in HIV-1 infection. Nat. Rev. Microbiol. 13:471-83
55. Chin CR, Perreira JM, Savidis G, Portmann JM, Aker AM, et al. 2015. Direct visualization of HIV-1 replication intermediates shows that capsid and CPSF6 modulate HIV-1 intra-nuclear invasion and integration. Cell Rep. 13:1717-31
56. Peng K, Muranyi W, Glass B, Laketa V, Yant SR, et al. 2014. Quantitative microscopy of functional HIV post-entry complexes reveals association of replication with the viral capsid. eLife 3:e04114
57. Li Q, Estes JD, Schlievert PM, Duan L, Brosnahan AJ, et al. 2009. Glycerol monolaurate prevents mucosal SIV transmission. Nature 458:1034-38
58. Malleret B,Maneglier B, Karlsson I, Lebon P, Nascimbeni M, et al. 2008. Primary infection with simian immunodeficiency virus: plasmacytoid dendritic cell homing to lymph nodes, type I interferon, and immune suppression. Blood 112:4598-608
59. Li Q, Duan L, Estes JD, Ma ZM, Rourke T, et al. 2005. Peak SIV replication in resting memory CD4+ T cells depletes gut lamina propria CD4+ T cells. Nature 434:1148-52
60. Lederer S, Favre D, Walters KA, Proll S, Kanwar B, et al. 2009. Transcriptional profiling in pathogenic and non-pathogenic SIV infections reveals significant distinctions in kinetics and tissue compartmentalization. PLOS Pathog. 5:e1000296
61. Barouch DH, Ghneim K, Bosche WJ, Li Y, Berkemeier B, et al. 2016. Rapid inflammasome activation following mucosal SIV infection of rhesus monkeys. Cell 165:656-67
62. Guarda G, Braun M, Staehli F, Tardivel A, Mattmann C, et al. 2011. Type I interferon inhibits interleukin-1 production and inflammasome activation. Immunity 34:213-23
63. Reboldi A, Dang EV, McDonald JG, Liang G, Russell DW, Cyster JG. 2014. 25-Hydroxycholesterol suppresses interleukin-1-driven inflammation downstream of type I interferon. Science 345:679-84
64. Franz KM, Kagan JC. 2017. Innate immune receptors as competitive determinants of cell fate. Mol. Cell 66:750-60
65. Kane M, Case LK, Kopaskie K, Kozlova A, MacDearmid C, et al. 2011. Successful transmission of a retrovirus depends on the commensal microbiota. Science 334:245-49
66. Sewald X, Ladinsky MS, Uchil PD, Beloor J, Pi R, et al. 2015. Retroviruses use CD169-mediated transinfection of permissive lymphocytes to establish infection. Science 350:563-67
67. Menager MM, Littman DR. 2016. Actin dynamics regulates dendritic cell-mediated transfer of HIV-1 to T cells. Cell 164:695-709
68. Izquierdo-UserosN, LorizateM, Puertas MC,Rodriguez-PlataMT, ZanggerN, et al. 2012. Siglec-1 is a novel dendritic cell receptor thatmediates HIV-1 trans-infection through recognition of viralmembrane gangliosides. PLOS Biol. 10:e1001448
69. Rempel H, Calosing C, Sun B, Pulliam L. 2008. Sialoadhesin expressed on IFN-induced monocytes binds HIV-1 and enhances infectivity. PLOS ONE 3:e1967
70. Nobile C, Petit C, Moris A, Skrabal K, Abastado JP, et al. 2005. Covert human immunodeficiency virus replication in dendritic cells and in DC-SIGN-expressing cells promotes long-term transmission to lymphocytes. J. Virol. 79:5386-99
71. Gummuluru S, Rogel M, Stamatatos L, Emerman M. 2003. Binding of human immunodeficiency virus type 1 to immature dendritic cells can occur independently of DC-SIGN and mannose binding C-type lectin receptors via a cholesterol-dependent pathway. J. Virol. 77:12865-74
72. Boggiano C, Manel N, Littman DR. 2007. Dendritic cell-mediated trans-enhancement of human immunodeficiency virus type 1 infectivity is independent of DC-SIGN. J. Virol. 81:2519-23
73. Arrighi JF, Pion M, Wiznerowicz M, Geijtenbeek TB, Garcia E, et al. 2004. Lentivirus-mediated RNA interference of DC-SIGN expression inhibits human immunodeficiency virus transmission from dendritic cells to T cells. J. Virol. 78:10848-55
74. Burleigh L, Lozach PY, Schiffer C, Staropoli I, Pezo V, et al. 2006. Infection of dendritic cells (DCs), not DC-SIGN-mediated internalization of human immunodeficiency virus, is required for long-term transfer of virus to T cells. J. Virol. 80:2949-57
75. Jacquelin B, Mayau V, Targat B, Liovat AS, Kunkel D, et al. 2009. Nonpathogenic SIV infection of African green monkeys induces a strong but rapidly controlled type I IFN response. J. Clin. Investig. 119:3544-55
76. Doyle T, Goujon C, Malim MH. 2015. HIV-1 and interferons: Who's interfering with whom? Nat. Rev. Microbiol. 13:403-13
77. Eickhoff S, Brewitz A, Gerner MY, Klauschen F, Komander K, et al. 2015. Robust anti-viral immunity requires multiple distinct T cell-dendritic cell interactions. Cell 162:1322-37
78. Hor JL, Whitney PG, Zaid A, Brooks AG, Heath WR, Mueller SN. 2015. Spatiotemporally distinct interactions with dendritic cell subsets facilitates CD4+ and CD8+ T cell activation to localized viral infection. Immunity 43:554-65
79. Greyer M, Whitney PG, Stock AT, Davey GM, Tebartz C, et al. 2016. T cell help amplifies innate signals in CD8+ DCs for optimal CD8+ T cell priming. Cell Rep. 14:586-97
80. Appay V, Papagno L, Spina CA, Hansasuta P, King A, et al. 2002. Dynamics of T cell responses in HIV infection. J. Immunol. 168:3660-66
81. Doisne J-M, Urrutia A, Lacabaratz-Porret C, Goujard C, Meyer L, et al. 2004. CD8+ T cells specific for EBV, cytomegalovirus, and influenza virus are activated during primary HIV infection. J. Immunol. 173:2410-18
82. Papagno L, Spina CA, Marchant A, Salio M, Rufer N, et al. 2004. Immune activation and CD8+ T-cell differentiation towards senescence in HIV-1 infection. PLOS Biol. 2:e20
83. Ndhlovu ZM, Kamya P, Mewalal N, Kloverpris HN, Nkosi T, et al. 2015. Magnitude and kinetics of CD8+ T cell activation during hyperacute HIV infection impact viral set point. Immunity 43:591-604
84. Takata H, Buranapraditkun S, Kessing C, Fletcher JL, Muir R, et al.; for RV254/SEARCH010 RV304/SEARCH013 Study Groups. 2017. Delayed differentiation of potent effector CD8+ T cells reducing viremia and reservoir seeding in acute HIV infection. Sci. Transl. Med. 9:eaag1809
85. Walker B, McMichael A. 2012. The T-cell response to HIV. Cold Spring Harb. Perspect. Med. 2:a007054
86. Koup RA, Safrit JT, Cao Y, Andrews CA, McLeod G, et al. 1994. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. J. Virol. 68:4650-55
87. Okoye A, Park H, Rohankhedkar M, Coyne-Johnson L, Lum R, et al. 2009. Profound CD4+/CCR5+ T cell expansion is induced by CD8+ lymphocyte depletion but does not account for accelerated SIV pathogenesis. J. Exp. Med. 206:1575-88
88. Henn MR, Boutwell CL, Charlebois P, Lennon NJ, Power KA, et al. 2012. Whole genome deep sequencing of HIV-1 reveals the impact of early minor variants upon immune recognition during acute infection. PLOS Pathog. 8:e1002529
89. Bailey JR, Williams TM, Siliciano RF, Blankson JN. 2006. Maintenance of viral suppression in HIV-1-infected HLA-B57+ elite suppressors despite CTL escape mutations. J. Exp. Med. 203:1357-69
90. Migueles SA, Weeks KA, Nou E, Berkley AM, Rood JE, et al. 2009. Defective human immunodeficiency virus-specific CD8+ T-cell polyfunctionality, proliferation, and cytotoxicity are not restored by antiretroviral therapy. J. Virol. 83:11876-89
91. Oxenius A, Price DA, Easterbrook PJ, O'Callaghan CA, Kelleher AD, et al. 2000. Early highly active antiretroviral therapy for acute HIV-1 infection preserves immune function of CD8+ and CD4+ T lymphocytes. PNAS 97(7):3382-87
92. Frange P, Faye A, Avettand-Fenoel V, Bellaton E, Descamps D, et al.; for ANRS EPF-CO10 Paediatr. Cohort, ANRS EP47 VISCONTI Study Group. 2016. HIV-1 virological remission lasting more than 12 years after interruption of early antiretroviral therapy in a perinatally infected teenager enrolled in the French ANRS EPF-CO10 paediatric cohort: a case report. Lancet HIV 3:e49-54
93. Saez-Cirion A, Bacchus C, Hocqueloux L, Avettand-Fenoel V, Girault I, et al.; ANRS VISCONTI Study Group. 2013. Post-treatment HIV-1 controllers with a long-term virological remission after the interruption of early initiated antiretroviral therapy ANRSVISCONTI Study. PLOS Pathog. 9:e1003211
94. Whitney JB, Hill AL, Sanisetty S, Penaloza-MacMaster P, Liu J, et al. 2014. Rapid seeding of the viral reservoir prior to SIV viraemia in rhesus monkeys. Nature 512:74-77
95. Pauken KE, Sammons MA,Odorizzi PM,Manne S, Godec J, et al. 2016. Epigenetic stability of exhausted T cells limits durability of reinvigoration by PD-1 blockade. Science 354:1160-65
96. Champagne P, Ogg GS, King AS, Knabenhans C, Ellefsen K, et al. 2001. Skewed maturation of memory HIV-specific CD8 T lymphocytes. Nature 410:106-11
97. Dalod M, Dupuis M, Deschemin J-C, Goujard C, Deveau C, et al. 1999. Weak anti-HIV CD8+ T-cell effector activity in HIV primary infection. J. Clin. Investig. 104:1431-39
98. Lecuroux C, Girault I, Cheret A, Versmisse P, Nembot G, et al; ANRS 147 OPTIPRIM Clin. Trial. 2013. CD8 T-cells from most HIV-infected patients lack ex vivo HIV-suppressive capacity during acute and early infection. PLOS ONE 8:e59767
99. Paiardini M, Cervasi B, Albrecht H,Muthukumar A, Dunham R, et al. 2005. Loss of CD127 expression defines an expansion of effector CD8+ T cells in HIV-infected individuals. J. Immunol. 174:2900-9
100. Trautmann L, Mbitikon-Kobo FM, Goulet JP, Peretz Y, Shi Y, et al. 2012. Profound metabolic, functional, and cytolytic differences characterize HIV-specific CD8 T cells in primary and chronic HIV infection. Blood 120:3466-77
101. Saez-Cirion A, Pancino G. 2013. HIV controllers: a genetically determined or inducible phenotype? Immunol. Rev. 254:281-94
102. Addo MM, Draenert R, Rathod A, Verrill CL, Davis BT, et al. 2007. Fully differentiated HIV-1 specific CD8+ T effector cells are more frequently detectable in controlled than in progressive HIV-1 infection. PLOS ONE 2:e321
103. Saez-Cirion A, LacabaratzC, Lambotte O, Versmisse P, Urrutia A, et al.; for ANRS EP36 HIVControll. Study Group. 2007. HIV controllers exhibit potent CD8 T cell capacity to suppress HIV infection ex vivo and peculiar cytotoxic T lymphocyte activation phenotype. PNAS 104:6776-81
104. Migueles SA, Osborne CM, Royce C, Compton AA, Joshi RP, et al. 2008. Lytic granule loading of CD8+ T cells is required for HIV-infected cell elimination associated with immune control. Immunity 29:1009-21
105. Shasha D, Karel D, Angiuli O, Greenblatt A, Ghebremichael M, et al. 2016. Elite controller CD8+ T cells exhibit comparable viral inhibition capacity, but better sustained effector properties compared to chronic progressors. J. Leukoc. Biol. 100:1425-33
106. Hersperger AR, Pereyra F, Nason M, Demers K, Sheth P, et al. 2010. Perforin expression directly ex vivo by HIV-specific CD8 T-cells is a correlate of HIV elite control. PLOS Pathog. 6:e1000917
107. Angin M, Wong G, Papagno L, Versmisse P, David A, et al.; for ANRS CO5 IMMUNOVIR-2 Study Group. 2016. Preservation of lymphopoietic potential and virus suppressive capacity by CD8+ T cells in HIV-2-infected controllers. J. Immunol. 197:2787-95
108. Thiebaut R, Matheron S, Taieb A, Brun-Vezinet F, Chene G, Autran B; for Immunol. Group ANRS CO5 HIV-2 Cohort. 2011. Long-term nonprogressors and elite controllers in the ANRS CO5 HIV-2 cohort. AIDS 25:865-67
109. van der Loeff MFS, Larke N, Kaye S, Berry N, Ariyoshi K, et al. 2010. Undetectable plasma viral load predicts normal survival in HIV-2-infected people in a West African village. Retrovirology 7:46
110. van Aalderen MC, Remmerswaal EBM, ten Berge IJM, van Lier RAW. 2014. Blood and beyond: properties of circulating and tissue-resident human virus-specific αβCD8+ Tcells. Eur. J. Immunol. 44:934-44
111. Hislop AD, Gudgeon NH, Callan MFC, Fazou C, Hasegawa H, et al. 2001. EBV-specific CD8+ T cell memory: relationships between epitope specificity, cell phenotype, and immediate effector function. J. Immunol. 167:2019-29
112. GreenoughTC, Straubhaar JR, Kamga L, Weiss ER, Brody RM, et al. 2015. A gene expression signature that correlates with CD8+ T cell expansion in acute EBV infection. J. Immunol. 195:4185-97
113. Hersperger AR,Martin JN, Shin LY, Sheth PM, Kovacs CM, et al. 2011. IncreasedHIV-specific CD8+ T-cell cytotoxic potential inHIVelite controllers is associated with T-bet expression. Blood 117:3799-808
114. Kaech SM, Tan JT,Wherry EJ, Konieczny BT, Surh CD, Ahmed R. 2003. Selective expression of the interleukin 7 receptor identifies effector CD8 T cells that give rise to long-lived memory cells. Nat. Immunol. 4:1191-98
115. Kaech SM, Wherry EJ. 2007. Heterogeneity and cell-fate decisions in effector and memory CD8+ T cell differentiation during viral infection. Immunity 27:393-405
116. Intlekofer AM,TakemotoN,Wherry EJ, Longworth SA, Northrup JT, et al. 2005. Effector and memory CD8+ T cell fate coupled by T-bet and eomesodermin. Nat. Immunol. 6:1236-44
117. Chang JT, Palanivel VR, Kinjyo I, Schambach F, Intlekofer AM, et al. 2007. Asymmetric T lymphocyte division in the initiation of adaptive immune responses. Science 315:1687-91
118. Gerlach C, Heijst JWJV, Swart E, Sie D, Armstrong N, et al. 2010. One naive T cell, multiple fates in CD8+ T cell differentiation. J. Exp. Med. 207:1235-46
119. Beuneu H, Lemaitre F, Deguine J, Moreau HD, Bouvier I, et al. 2010. Visualizing the functional diversification of CD8+ T cell responses in lymph nodes. Immunity 33:412-23
120. Hu JK, Kagari T, Clingan JM, Matloubian M. 2011. Expression of chemokine receptor CXCR3 on T cells affects the balance between effector and memory CD8 T-cell generation. PNAS 108:E118-27
121. King CG, Koehli S, Hausmann B, Schmaler M, Zehn D, Palmer E. 2012. T cell affinity regulates asymmetric division, effector cell differentiation, and tissue pathology. Immunity 37:709-20
122. Bachmann MF, Speiser DE, Ohashi PS. 1997. Functional maturation of an antiviral cytotoxic T-cell response. J. Virol. 71:5764-68
123. Busch DH, Pamer EG. 1999. T cell affinity maturation by selective expansion during infection. J. Exp. Med. 189:701-10
124. Zehn D, Lee SY, Bevan MJ. 2009. Complete but curtailed T-cell response to very low-affinity antigen. Nature 458:211-14
125. LichterfeldM, Yu XG, Mui SK, Williams KL, Trocha A, et al. 2007. Selective depletion of high-avidity human immunodeficiency virus type 1 (HIV-1)-specific CD8+ T cells after early HIV-1 infection. J. Virol. 81:4199-214
126. Almeida JR, Price DA, Papagno L, Arkoub ZA, Sauce D, et al. 2007. Superior control of HIV-1 replication by CD8+ T cells is reflected by their avidity, polyfunctionality, and clonal turnover. J. Exp. Med. 204:2473-85
127. Lecuroux C, Saez-Cirion A, Girault I, Versmisse P, Boufassa F, et al. 2014. Both HLA-B57 and plasma HIV RNA levels contribute to the HIV-specific CD8+ T cell response in HIV controllers. J. Virol. 88:176-87
128. Ozga AJ, Moalli F, Abe J, Swoger J, Sharpe J, et al. 2016. pMHC affinity controls duration of CD8+ T cell-DC interactions and imprints timing of effector differentiation versus expansion. J. Exp. Med. 213:2811-29
129. Joshi NS, CuiW, Chandele A, Lee HK, Urso DR, et al. 2007. Inflammation directs memory precursor and short-lived effector CD8+ T cell fates via the graded expression of T-bet transcription factor. Immunity 27:281-95
130. Kurachi M, Kurachi J, Suenaga F, Tsukui T, Abe J, et al. 2011. Chemokine receptor CXCR3 facilitates CD8+ T cell differentiation into short-lived effector cells leading to memory degeneration. J. Exp.Med. 208:1605-20
131. Jacquelin B, Mayau V, Targat B, Liovat A-S, Kunkel D, et al. 2009. Nonpathogenic SIV infection of African green monkeys induces a strong but rapidly controlled type I IFN response. J. Clin. Investig. 119:3544-55
132. Malleret B,Maneglier B, Karlsson I, Lebon P, Nascimbeni M, et al. 2008. Primary infection with simian immunodeficiency virus: plasmacytoid dendritic cell homing to lymph nodes, type I interferon, and immune suppression. Blood 112:4598-608
133. Mattapallil JJ, Douek DC, Hill B, Nishimura Y, Martin M, Roederer M. 2005. Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection. Nature 434:1093-97
134. Stacey AR, Norris PJ, Qin L, Haygreen EA, Taylor E, et al. 2009. Induction of a striking systemic cytokine cascade prior to peak viremia in acute human immunodeficiency virus type 1 infection, in contrast to more modest and delayed responses in acute hepatitis B and C virus infections. J. Virol. 83:3719-33
135. Zou W, Lackner AA, Simon M, Durand-Gasselin I, Galanaud P, et al. 1997. Early cytokine and chemokine gene expression in lymph nodes of macaques infected with simian immunodeficiency virus is predictive of disease outcome and vaccine efficacy. J. Virol. 71:1227-36
136. Estes JD, Li Q, Reynolds MR, Wietgrefe S, Duan L, et al. 2006. Premature induction of an immunosuppressive regulatory T cell response during acute simian immunodeficiency virus infection. J. Infect. Dis. 193:703-12
137. Douek DC, Brenchley JM, Betts MR, Ambrozak DR, Hill BJ, et al. 2002. HIV preferentially infects HIV-specific CD4+ T cells. Nature 417:95-98
138. Huang J,Burke PS,CungTDH,Pereyra F,Toth I, et al. 2010. Leukocyte immunoglobulin-like receptors maintain unique antigen-presenting properties of circulating myeloid dendritic cells in HIV-1-infected elite controllers. J. Virol. 84:9463-71
139. Chen H, Li C, Huang J, Cung T, Seiss K, et al. 2011. CD4+ T cells from elite controllers resist HIV-1 infection by selective upregulation of p21. J. Clin. Investig. 121:1549-60
140. Saez-Cirion A, Hamimi C, Bergamaschi A, David A, Versmisse P, et al. 2011. Restriction of HIV-1 replication in macrophages and CD4+ T cells from HIV controllers. Blood 118:955-64
141. Hamimi C, DavidA,Versmisse P, WeissL,Bruel T, et al.;ANRSCO21CODEXcohort. 2016. Dendritic cells from HIV controllers have low susceptibility toHIV-1 infection in vitro but high capacity to capture HIV-1 particles. PLOS ONE 11:e0160251
142. Martin-Gayo E, Buzon MJ, Ouyang Z, Hickman T, Cronin J, et al. 2015. Potent cell-intrinsic immune responses in dendritic cells facilitate HIV-1-specific T cell immunity in HIV-1 elite controllers. PLOS Pathog. 11:e1004930
143. Vingert B, Benati D, Lambotte O, de Truchis P, Slama L, et al. 2012. HIV controllers maintain a population of highly efficient Th1 effector cells in contrast to patients treated in the long term. J. Virol. 86:10661-74
144. Rosenberg ES, Billingsley JM, Caliendo AM, Boswell SL, Sax PE, et al. 1997. Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia. Science 278:1447-50
145. Soghoian DZ, Jessen H, Flanders M, Sierra-Davidson K, Cutler S, et al. 2012. HIV-specific cytolytic CD4 T cell responses during acute HIV infection predict disease outcome. Sci. Transl. Med. 4:123ra25
146. Chevalier MF, J ulg B, Pyo A, Flanders M, Ranasinghe S, et al. 2011. HIV-1-specific interleukin-21+ CD4+ T cell responses contribute to durable viral control through the modulation of HIV-specific CD8+ T cell function. J. Virol. 85:733-41
147. Kalams SA, Buchbinder SP, Rosenberg ES, Billingsley JM, Colbert DS, et al. 1999. Association between virus-specific cytotoxic T-lymphocyte and helper responses in human immunodeficiency virus type 1 infection. J. Virol. 73:6715-20
148. Okoye AA, Picker LJ. 2013. CD4+ T-cell depletion in HIV infection: mechanisms of immunological failure. Immunol. Rev. 254:54-64
149. Benati D, Galperin M, Lambotte O, Gras S, LimA, et al. 2016. PublicTcell receptors confer high-avidity CD4 responses to HIV controllers. J. Clin. Investig. 126:2093-108
150. Duvall MG, Precopio ML, Ambrozak DA, Jaye A, McMichael AJ, et al. 2008. Polyfunctional T cell responses are a hallmark of HIV-2 infection. Eur J. Immunol. 38:350-63
151. Potter SJ, Lacabaratz C, Lambotte O, Perez-Patrigeon S, Vingert B, et al. 2007. Preserved centralmemory and activated effector memory CD4+ T-cell subsets in human immunodeficiency virus controllers: an ANRS EP36 study. J. Virol. 81:13904-15
152. Melamed A, Laydon DJ, Al Khatib H, Rowan AG, Taylor GP, Bangham CR. 2015. HTLV-1 drives vigorous clonal expansion of infected CD8+ T cells in natural infection. Retrovirology 12:91
153. Greten TF, Slansky JE, Kubota R, Soldan SS, Jaffee EM, et al. 1998. Direct visualization of antigenspecific T cells: HTLV-1 Tax11-19-specific CD8+ T cells are activated in peripheral blood and accumulate in cerebrospinal fluid from HAM/TSP patients. PNAS 95:7568-73
154. Rowan AG, Witkover A, Melamed A, Tanaka Y, Cook LB, et al. 2016. T cell receptor Vβ staining identifies the malignant clone in adult T cell leukemia and reveals killing of leukemia cells by autologous CD8+ T cells. PLOS Pathog. 12:e1006030
155. Hasenkrug KJ, Dittmer U. 2000. The role of CD4 and CD8 T cells in recovery and protection from retroviral infection: lessons from the Friend virus model. Virology 272:244-49
156. Hasenkrug KJ, Chesebro B. 1997. Immunity to retroviral infection: the Friend virus model. PNAS 94:7811-16
157. Santiago ML, Montano M, Benitez R, Messer RJ, Yonemoto W, et al. 2008. Apobec3 encodes Rfv3, a gene influencing neutralizing antibody control of retrovirus infection. Science 321:1343-46
158. Tomaras GD, Haynes BF. 2009. HIV-1-specific antibody responses during acute and chronic HIV-1 infection. Curr. Opin. HIV AIDS 4:373-79
159. Victora GD, Mouquet H. 2017. What are the primary limitations in B-cell affinity maturation, and how much affinity maturation can we drive with vaccination? Lessons from the antibody response to HIV-1. Cold Spring Harb. Perspect. Biol. In press
160. Mouquet H. 2014. Antibody B cell responses in HIV-1 infection. Trends Immunol. 35:549-61
161. Rusert P, Kouyos RD, Kadelka C, Ebner H, Schanz M, et al.; Swiss HIV Cohort Study. 2016. Determinants of HIV-1 broadly neutralizing antibody induction. Nat. Med. 22:1260-67
162. Klein F, Diskin R, Scheid JF,Gaebler C, MouquetH, et al. 2013. Somaticmutations of the immunoglobulin framework are generally required for broad and potent HIV-1 neutralization. Cell 153:126-38
163. Kelsoe G, Haynes BF. 2017. What are the primary limitations in B-cell affinity maturation, and how much affinity maturation can we drive with vaccination? Breaking through immunity's glass ceiling. Cold Spring Harb. Perspect. Biol. In press
164. Moir S, Fauci AS. 2013. Insights into B cells and HIV-specific B-cell responses in HIV-infected individuals. Immunol. Rev. 254:207-24
165. Keele BF, Tazi L, Gartner S, Liu Y, Burgon TB, et al. 2008. Characterization of the follicular dendritic cell reservoir of human immunodeficiency virus type 1. J. Virol. 82:5548-61
166. Perreau M, Savoye A-L, Crignis ED, Corpataux J-M, Cubas R, et al. 2013. Follicular helper T cells serve as the major CD4 T cell compartment for HIV-1 infection, replication, and production. J. Exp. Med. 210:143-56
167. Boritz EA, Darko S, Swaszek L, Wolf G, Wells D, et al. 2016. Multiple origins of virus persistence during natural control of HIV infection. Cell 166:1004-15
168. Ackerman ME, Mikhailova A, Brown EP, Dowell KG, Walker BD, et al. 2016. Polyfunctional HIVspecific antibody responses are associated with spontaneous HIV control. PLOS Pathog. 12:e1005315
169. Lambotte O, Pollara J, Boufassa F, Moog C, Venet A, et al. 2013. High antibody-dependent cellular cytotoxicity responses are correlated with strong CD8 T cell viral suppressive activity but not with B57 status in HIV-1 elite controllers. PLOS ONE 8:e74855
170. Yates NL, Lucas JT, Nolen TL, Vandergrift NA, Soderberg KA, et al. 2011. Multiple HIV-1-specific IgG3 responses decline during acute HIV-1: implications for detection of incident HIV infection. AIDS 25:2089-97
171. Devito C, Broliden K, Kaul R, Svensson L, Johansen K, et al. 2000. Mucosal and plasma IgA from HIV-1-exposed uninfected individuals inhibit HIV-1 transcytosis across human epithelial cells. J. Immunol. 165:5170-76
172. Leeansyah E, Ganesh A, Quigley MF, Sonnerborg A, Andersson J, et al. 2013. Activation, exhaustion, and persistent decline of the antimicrobial MR1-restricted MAIT-cell population in chronic HIV-1 infection. Blood 121:1124-35
173. Korner C, Granoff ME, Amero MA, Sirignano MN, Vaidya SA, et al. 2014. Increased frequency and function of KIR2DL1-3+ NK cells in primary HIV-1 infection are determined by HLA-C group haplotypes. Eur. J. Immunol. 44:2938-48
174. Elemans M, Boelen L, Rasmussen M, Buus S, Asquith B. 2017. HIV-1 adaptation to NK cell-mediated immune pressure. PLOS Pathog. 13:e1006361
175. Alter G, Heckerman D, Schneidewind A, Fadda L, Kadie CM, et al. 2011. HIV-1 adaptation to NKcell-mediated immune pressure. Nature 476:96-100
176. Young GR, Eksmond U, Salcedo R, Alexopoulou L, Stoye JP, Kassiotis G. 2012. Resurrection of endogenous retroviruses in antibody-deficient mice. Nature 491:774-78
177. Garrison KE, Jones RB, Meiklejohn DA, Anwar N, Ndhlovu LC, et al. 2007. T cell responses to human endogenous retroviruses in HIV-1 infection. PLOS Pathog. 3:e165
178. Zeng M, Hu Z, Shi X, Li X, Zhan X, et al. 2014. MAVS, cGAS, and endogenous retroviruses in Tindependent B cell responses. Science 346:1486-92
179. Axer A, Halperin N. 1972. Heterogenous transplant (Kiel bone) for the operative treatment of scoliosis. Arch. Orthop. Unfallchir. 72:207-14
180. Cheng L, YuH, Li G, Li F,Ma J, et al. 2017. Type I interferons suppress viral replication but contribute to T cell depletion and dysfunction during chronic HIV-1 infection. JCI Insight 2:e94366
181. Hua S, Lecuroux C, Saez-Cirion A, Pancino G, Girault I, et al. 2014. Potential role for HIV-specific CD38-/HLA-DR+ CD8+ T cells in viral suppression and cytotoxicity in HIV controllers. PLOS ONE 9:e101920
182. Loo CP, Snyder CM, Hill AB. 2017. Blocking virus replication during acute murine cytomegalovirus infection paradoxically prolongs antigen presentation and increases the CD8+ T cell response by preventing type I IFN-dependent depletion of dendritic cells. J. Immunol. 198:383-93
183. Rothlin CV, Ghosh S, Zuniga EI, Oldstone MB, Lemke G. 2007. TAM receptors are pleiotropic inhibitors of the innate immune response. Cell 131:1124-36
184. Janeway CA Jr. 1989. Approaching the asymptote? Evolution and revolution in immunology. Cold Spring Harb. Symp. Quant. Biol. 54(Part 1):1-13
185. Pulendran B, Ahmed R. 2011. Immunological mechanisms of vaccination. Nat. Immunol. 12:509-17
186. Pichlmair A, Schulz O, Tan CP, Naslund TI, Liljestrom P, et al. 2006. RIG-I-mediated antiviral responses to single-stranded RNA bearing 5-phosphates. Science 314:997-1001
187. Bowie AG, Unterholzner L. 2008. Viral evasion and subversion of pattern-recognition receptor signalling. Nat. Rev. Immunol. 8:911-22
188. Schwartz O, Marechal V, Le Gall S, Lemonnier F, Heard JM. 1996. Endocytosis of major histocompatibility complex class I molecules is induced by the HIV-1 Nef protein. Nat. Med. 2:338-42
189. Pillai PS, Molony RD, Martinod K, Dong H, Pang IK, et al. 2016. Mx1 reveals innate pathways to antiviral resistance and lethal influenza disease. Science 352:463-66
190. Mellman I, Steinman RM. 2001. Dendritic cells: specialized and regulated antigen processing machines. Cell 106:255-58
191. Courreges MC, Burzyn D, Nepomnaschy I, Piazzon I, Ross SR. 2007. Critical role of dendritic cells in mouse mammary tumor virus in vivo infection. J. Virol. 81:3769-77
192. Duvall MG, Lore K, Blaak H, Ambrozak DA, AdamsWC, et al. 2007. Dendritic cells are less susceptible to human immunodeficiency virus type 2 (HIV-2) infection than to HIV-1 infection. J. Virol. 81:13486-98
193. Chauveau L, Puigdomenech I, Ayinde D, Roesch F, Porrot F, et al. 2015. HIV-2 infects resting CD4+ T cells but not monocyte-derived dendritic cells. Retrovirology 12:2
194. Chauveau L, Donahue DA, Monel B, Porrot F, Bruel T, et al. 2017. HIV fusion in dendritic cells occurs mainly at the surface and is limited by low CD4 levels. J. Virol. 21:e01248-17
195. HonkeN, ShaabaniN, Cadeddu G, Sorg UR, Zhang DE, et al. 2011. Enforced viral replication activates adaptive immunity and is essential for the control of a cytopathic virus. Nat. Immunol. 13:51-57
196. Baldauf HM, Stegmann L, Schwarz SM, Ambiel I, Trotard M, et al. 2017. Vpx overcomes a SAMHD1-independent block toHIVreverse transcription that is specific to restingCD4Tcells.PNAS114:2729-34
197. Yu H, Usmani SM, Borch A, Kramer J, Sturzel CM, et al. 2013. The efficiency of Vpx-mediated SAMHD1 antagonism does not correlate with the potency of viral control in HIV-2-infected individuals. Retrovirology 10:27
198. Shingai M, Welbourn S, Brenchley JM, Acharya P, Miyagi E, et al. 2015. The expression of functional Vpx during pathogenic SIVmac infections of rhesus macaques suppresses SAMHD1 in CD4+ memory T cells. PLOS Pathog. 11:e1004928
199. Gramberg T, Kahle T, Bloch N,Wittmann S,Mullers E, et al. 2013. Restriction of diverse retroviruses by SAMHD1. Retrovirology 10:26
200. Varol C, Vallon-Eberhard A, Elinav E, Aychek T, Shapira Y, et al. 2009. Intestinal lamina propria dendritic cell subsets have different origin and functions. Immunity 31:502-12
201. Segura E, Valladeau-Guilemond J, Donnadieu MH, Sastre-Garau X, Soumelis V, Amigorena S. 2012. Characterization of resident and migratory dendritic cells in human lymph nodes. J. Exp.Med. 209:653-60
202. Hasenkrug KJ, Dittmer U. 2007. Immune control and prevention of chronic Friend retrovirus infection. Front. Biosci. 12:1544-51
203. Browne EP, Littman DR. 2009. Myd88 is required for an antibody response to retroviral infection. PLOS Pathog. 5:e1000298
204. Kirchhoff F. 2010. Immune evasion and counteraction of restriction factors byHIV-1 and other primate lentiviruses. Cell Host Microbe 8:55-67
205. Lim ES, Fregoso OI, McCoy CO, Matsen FA, Malik HS, Emerman M. 2012. The ability of primate lentiviruses to degrade the monocyte restriction factorSAMHD1preceded the birth of the viral accessory protein Vpx. Cell Host Microbe 11:194-204
206. Sun L,Wu J, Du F, Chen X, Chen ZJ. 2013. Cyclic GMP-AMP synthase is a cytosolic DNA sensor that activates the type I interferon pathway. Science 339:786-91
207. Descours B, Petitjean G, Lopez-Zaragoza JL, Bruel T, Raffel R, et al. 2017. CD32a is a marker of a CD4 T-cell HIV reservoir harbouring replication-competent proviruses. Nature 543:564-67
208. Connick E, Mattila T, Folkvord JM, Schlichtemeier R, Meditz AL, et al. 2007. CTL fail to accumulate at sites of HIV-1 replication in lymphoid tissue. J. Immunol. 178:6975-83
209. Petrovas C, Ferrando-Martinez S, Gerner MY, Casazza JP, Pegu A, et al. 2017. Follicular CD8 T cells accumulate in HIV infection and can kill infected cells in vitro via bispecific antibodies. Sci. Transl.Med. 9:eaag2285
210. Perreau M, Savoye AL, De Crignis E, Corpataux JM, Cubas R, et al. 2013. Follicular helper T cells serve as the major CD4 T cell compartment for HIV-1 infection, replication, and production. J. Exp. Med. 210:143-56
211. Stetson DB, Ko JS, Heidmann T,Medzhitov R. 2008. Trex1 prevents cell-intrinsic initiation of autoimmunity. Cell 134:587-98
212. Crow YJ, Manel N. 2015. Aicardi-Goutieres syndrome and the type I interferonopathies. Nat. Rev. Immunol. 15:429-40
213. Vance RE, Isberg RR, Portnoy DA. 2009. Patterns of pathogenesis: discrimination of pathogenic and nonpathogenic microbes by the innate immune system. Cell Host Microbe 6:10-21
214. Galao RP, Le Tortorec A Pickering S, Kueck T, Neil SJ. 2012. Innate sensing of HIV-1 assembly by Tetherin induces NFkB-dependent proinflammatory responses. Cell Host Microbe 12:633-44
215. Chae E, Tran DT,WeigelD. 2016. Cooperation and conflict in the plant immune system. PLOS Pathog. 12:e1005452
216. BaldaufHM, PanX, Erikson E, Schmidt S,DaddachaW, et al. 2012.SAMHD1restrictsHIV-1 infection in resting CD4+ T cells. Nat. Med. 18:1682-87
217. Parrish NF, Gao F, Li H, Giorgi EE, Barbian HJ, et al. 2013. Phenotypic properties of transmitted founder HIV-1. PNAS 110:6626-33
218. Sandler NG, Bosinger SE, Estes JD, Zhu RT, Tharp GK, et al. 2014. Type I interferon responses in rhesus macaques prevent SIV infection and slow disease progression. Nature 511:601-5
219. Deeks SG, Kitchen CM, Liu L, Guo H, Gascon R, et al. 2004. Immune activation set point during early HIV infection predicts subsequent CD4+ T-cell changes independent of viral load. Blood 104:942-47
220. Wherry EJ, Ha SJ, Kaech SM, HainingWN, Sarkar S, et al. 2007. Molecular signature of CD8+ T cell exhaustion during chronic viral infection. Immunity 27:670-84
221. Day CL, Kaufmann DE, Kiepiela P, Brown JA, Moodley ES, et al. 2006. PD-1 expression on HIVspecific T cells is associated with T-cell exhaustion and disease progression. Nature 443:350-54